These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 37403870)

  • 1. Expanding Chemical Probe Space: Quality Criteria for Covalent and Degrader Probes.
    Hartung IV; Rudolph J; Mader MM; Mulder MPC; Workman P
    J Med Chem; 2023 Jul; 66(14):9297-9312. PubMed ID: 37403870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PROTAC degraders as chemical probes for studying target biology and target validation.
    Němec V; Schwalm MP; Müller S; Knapp S
    Chem Soc Rev; 2022 Sep; 51(18):7971-7993. PubMed ID: 36004812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of reversible and irreversible covalent chemistry in targeted protein degradation.
    Kiely-Collins H; Winter GE; Bernardes GJL
    Cell Chem Biol; 2021 Jul; 28(7):952-968. PubMed ID: 33789091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones.
    Ishida T; Ciulli A
    SLAS Discov; 2021 Apr; 26(4):484-502. PubMed ID: 33143537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligandability of E3 Ligases for Targeted Protein Degradation Applications.
    Belcher BP; Ward CC; Nomura DK
    Biochemistry; 2023 Feb; 62(3):588-600. PubMed ID: 34473924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Human Carbonic Anhydrase II Heterobifunctional Degraders.
    O'Herin CB; Moriuchi YW; Bemis TA; Kohlbrand AJ; Burkart MD; Cohen SM
    J Med Chem; 2023 Feb; 66(4):2789-2803. PubMed ID: 36735827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the ligand spaces for E3 ligases for the design of protein degraders.
    Shah Zaib Saleem R; Schwalm MP; Knapp S
    Bioorg Med Chem; 2024 May; 105():117718. PubMed ID: 38621319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rise of covalent proteolysis targeting chimeras.
    Gabizon R; London N
    Curr Opin Chem Biol; 2021 Jun; 62():24-33. PubMed ID: 33549806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Guided Design and Optimization of Covalent VHL-Targeted Sulfonyl Fluoride PROTACs.
    Shah RR; De Vita E; Sathyamurthi PS; Conole D; Zhang X; Fellows E; Dickinson ER; Fleites CM; Queisser MA; Harling JD; Tate EW
    J Med Chem; 2024 Mar; 67(6):4641-4654. PubMed ID: 38478885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cereblon target validation using a covalent inhibitor of neosubstrate recruitment.
    Dann GP; Liu H; Nowak RP; Jones LH
    Methods Enzymol; 2023; 681():155-167. PubMed ID: 36764755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breaking Bad Proteins-Discovery Approaches and the Road to Clinic for Degraders.
    Bouvier C; Lawrence R; Cavallo F; Xolalpa W; Jordan A; Hjerpe R; Rodriguez MS
    Cells; 2024 Mar; 13(7):. PubMed ID: 38607017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A direct high-throughput protein quantification strategy facilitates discovery and characterization of a celastrol-derived BRD4 degrader.
    Payne NC; Maksoud S; Tannous BA; Mazitschek R
    Cell Chem Biol; 2022 Aug; 29(8):1333-1340.e5. PubMed ID: 35649410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein degraders - from thalidomide to new PROTACs.
    Ito T
    J Biochem; 2024 Apr; 175(5):507-519. PubMed ID: 38140952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-Molecule Degraders beyond PROTACs-Challenges and Opportunities.
    Kastl JM; Davies G; Godsman E; Holdgate GA
    SLAS Discov; 2021 Apr; 26(4):524-533. PubMed ID: 33632029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of cellular degradation kinetics for understanding mechanisms in targeted protein degradation.
    Riching KM; Caine EA; Urh M; Daniels DL
    Chem Soc Rev; 2022 Jul; 51(14):6210-6221. PubMed ID: 35792307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted protein degradation: Emerging concepts and protein state-specific targeting principles.
    Tao AJ; Gadbois GE; Buczynski SA; Ferguson FM
    Curr Opin Chem Biol; 2022 Apr; 67():102114. PubMed ID: 35042023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible Covalent PROTACs: Novel and Efficient Targeted Degradation Strategy.
    Yuan M; Chu Y; Duan Y
    Front Chem; 2021; 9():691093. PubMed ID: 34291036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical Model for Covalent Proteolysis Targeting Chimeras: Thermodynamics and Kinetics Underlying Catalytic Efficiency.
    Chaudhry C
    J Med Chem; 2023 May; 66(9):6239-6250. PubMed ID: 37102218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic approaches advancing targeted protein degradation.
    Sathe G; Sapkota GP
    Trends Pharmacol Sci; 2023 Nov; 44(11):786-801. PubMed ID: 37778939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chasing molecular glue degraders: screening approaches.
    Domostegui A; Nieto-Barrado L; Perez-Lopez C; Mayor-Ruiz C
    Chem Soc Rev; 2022 Jul; 51(13):5498-5517. PubMed ID: 35723413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.